Long-Term Liabilities: The sum of all non-current liabilities.
Neurogene Inc. (NGNE) had Long-Term Liabilities of $8.62M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-22.02M |
|
-- |
|
-- |
|
$26.08M |
|
$-26.08M |
|
$4.07M |
|
$-22.02M |
|
$-22.02M |
|
$-22.02M |
|
$-22.02M |
|
$-22.02M |
|
$-22.02M |
|
$-26.08M |
|
$-26.79M |
|
21.05M |
|
21.05M |
|
$-1.05 |
|
$-1.05 |
|
| Balance Sheet Financials | |
$278.99M |
|
$14.25M |
|
$18.33M |
|
$297.32M |
|
$15.44M |
|
$0.01M |
|
|
Long-Term Liabilities |
$8.62M |
$24.06M |
|
$273.25M |
|
$273.25M |
|
$273.25M |
|
14.27M |
|
| Cash Flow Statement Financials | |
$-40.24M |
|
$-37.59M |
|
$0.06M |
|
$136.93M |
|
$59.15M |
|
$-77.77M |
|
$7.46M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
18.07 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-41.16M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-8.06% |
|
-8.06% |
|
-7.40% |
|
-8.06% |
|
$19.15 |
|
$-1.96 |
|
$-1.91 |
|